143 related articles for article (PubMed ID: 3717935)
1. Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs.
Samuel J; Gill MJ; Iwashina T; Tovell DR; Tyrrell DL; Knaus EE; Wiebe LI
Antimicrob Agents Chemother; 1986 Feb; 29(2):320-4. PubMed ID: 3717935
[TBL] [Abstract][Full Text] [Related]
2. Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.
Gill MJ; Samuel J; Wiebe LI; Knaus EE; Tyrrell DL
Antimicrob Agents Chemother; 1984 Apr; 25(4):476-8. PubMed ID: 6732216
[TBL] [Abstract][Full Text] [Related]
3. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
Balzarini J; Bernaerts R; Verbruggen A; De Clercq E
Mol Pharmacol; 1990 Mar; 37(3):402-7. PubMed ID: 2156154
[TBL] [Abstract][Full Text] [Related]
4. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
Kit S; Ichimura H; De Clercq E
Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 131I, 125I and 82Br labelled (E)-5-(2-halovinyl)-2'-deoxyuridines.
Samuel J; Knaus EE; Wiebe LI; Tyrrell DL
Int J Appl Radiat Isot; 1984 Nov; 35(11):1049-52. PubMed ID: 6526520
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2-[125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy.
Morin KW; Atrazheva ED; Knaus EE; Wiebe LI
J Med Chem; 1997 Jul; 40(14):2184-90. PubMed ID: 9216837
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis.
Iwashina T; Tovell DR; Xu L; Tyrrell DL; Knaus EE; Wiebe LI
Drug Des Deliv; 1988 Dec; 3(4):309-21. PubMed ID: 2855580
[TBL] [Abstract][Full Text] [Related]
8. Simple quantitative radioiodination of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by exchange labelling.
Verbruggen A; Julien C; De Clercq E; De Roo M
Int J Rad Appl Instrum A; 1986; 37(4):355-7. PubMed ID: 3021658
[TBL] [Abstract][Full Text] [Related]
9. Liposomes for targeted delivery of radioiodinated IVdU and 3-CH3-IVdU for non-invasive detection of herpes simplex virus encephalitis in mice.
Stathaki S; Wiebe LI; Knaus EE; Rogers JA; Tovell D; Tyrrell DL
Drug Des Deliv; 1988 Nov; 3(3):223-34. PubMed ID: 2855578
[TBL] [Abstract][Full Text] [Related]
10. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
[TBL] [Abstract][Full Text] [Related]
11. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
12. Specific neuro-radiological diagnosis of herpes encephalitis in an animal model.
Cleator GM; Klapper PE; Lewis AG; Sharma HL; Longson M
Arch Virol; 1988; 101(1-2):1-12. PubMed ID: 3415476
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
14. Penetration of the blood-brain barrier by the antiviral drug (E)-5-(2-iodovinyl)-2'-deoxyuridine in a rat model of herpes encephalitis.
Klapper PE; Cleator GM; Bruce JM; Longson M
Drug Des Deliv; 1988 Jul; 3(1):57-67. PubMed ID: 2855575
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the carbocyclic analogue of (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells. Incorporation of C-IVDU into DNA.
De Clercq E; Bernaerts R; Balzarini J; Herdewijn P; Verbruggen A
J Biol Chem; 1985 Sep; 260(19):10621-8. PubMed ID: 2993282
[TBL] [Abstract][Full Text] [Related]
16. In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats.
Choi TH; Ahn SH; Kwon HC; Choi CW; Awh OD; Lim SM
Appl Radiat Isot; 2004 Jan; 60(1):15-21. PubMed ID: 14687631
[TBL] [Abstract][Full Text] [Related]
17. Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.
Descamps J; De Clercq E
J Biol Chem; 1981 Jun; 256(12):5973-6. PubMed ID: 6263899
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of carbocyclic (E)-5-(2-iodovinyl)-2'-deoxyuridine (C-IVDU) into DNA of herpes simplex virus-infected cells.
Bernaerts R; De Clercq E; Balzarini J; Herdewijn P; Verbruggen A
Antiviral Res; 1985; Suppl 1():51-6. PubMed ID: 3002266
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
[TBL] [Abstract][Full Text] [Related]
20. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
